Current opportunities and challenges in ALK-positive lung cancer

被引:4
作者
Lin, Jessica J. [1 ]
Gainor, Justin F. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
关键词
ALK-positive lung cancer; non-small cell lung cancer (NSCLC); targeted therapy; PHASE-II; ALECTINIB; NSCLC; SAFETY;
D O I
10.21037/tlcr-2023-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 4
页数:4
相关论文
共 28 条
[1]   Patient-led advocacy in ALK-positive lung cancer [J].
Barton, Colin ;
Al Achkar, Morhaf ;
Blender, Jennifer A. ;
Farmen, Summer Hall ;
Hall, Raymond B. ;
Konidari, Afroditi Maria ;
Martinez, Debbi ;
Pronsati, Nancee ;
Rosenzweig, Marc ;
Vass, Carla ;
Venanzi, Emily S. ;
Westlake, William ;
Muskavitch, Marc A. T. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06) :1303-1319
[2]   Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer [J].
Cabanos, Heidie Frisco ;
Hata, Aaron N. .
CANCERS, 2021, 13 (11)
[3]   Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer [J].
Camidge, D. R. ;
Kim, H. R. ;
Ahn, M. -J. ;
Yang, J. C. -H. ;
Han, J. -Y. ;
Lee, J. -S. ;
Hochmair, M. J. ;
Li, J. Y. -C. ;
Chang, G. -C. ;
Lee, K. H. ;
Gridelli, C. ;
Delmonte, A. ;
Garcia Campelo, R. ;
Kim, D. -W. ;
Bearz, A. ;
Griesinger, F. ;
Morabito, A. ;
Felip, E. ;
Califano, R. ;
Ghosh, S. ;
Spira, A. ;
Gettinger, S. N. ;
Tiseo, M. ;
Gupta, N. ;
Haney, J. ;
Kerstein, D. ;
Popat, S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (21) :2027-2039
[4]   Optimal first-line treatment for metastatic ALK plus non-small cell lung cancer-a narrative review [J].
Chazan, Grace ;
Solomon, Benjamin J. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (02) :369-378
[5]  
Chen MF, 2023, TRANSL LUNG CANCER R, V12, P337, DOI 10.21037/tlcr-22-631
[6]   Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management [J].
Cooper, Alissa J. ;
Sequist, Lecia, V ;
Lin, Jessica J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (08) :499-514
[7]   Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis [J].
Dagogo-Jack, Ibiayi ;
Kiedrowski, Lesli A. ;
Heist, Rebecca S. ;
Lin, Jessica J. ;
Meador, Catherine B. ;
Krueger, Elizabeth A. ;
Do, Andrew ;
Peterson, Jennifer ;
V. Sequist, Lecia ;
Gainor, Justin F. ;
Lennerz, Jochen K. ;
Digumarthy, Subba R. .
JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (08)
[8]   MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer [J].
Dagogo-Jack, Ibiayi ;
Yoda, Satoshi ;
Lennerz, Jochen K. ;
Langenbucher, Adam ;
Lin, Jessica J. ;
Rooney, Marguerite M. ;
Prutisto-Chang, Kylie ;
Oh, Audris ;
Adams, Nathaniel A. ;
Yeap, Beow Y. ;
Chin, Emily ;
Do, Andrew ;
Marble, Hetal D. ;
Stevens, Sara E. ;
Digumarthy, Subba R. ;
Saxena, Ashish ;
Nagy, Rebecca J. ;
Benes, Cyril H. ;
Azzoli, Christopher G. ;
Lawrence, Michael S. ;
Gainor, Justin F. ;
Shaw, Alice T. ;
Hata, Aaron N. .
CLINICAL CANCER RESEARCH, 2020, 26 (11) :2535-2545
[9]   Strategies to overcome resistance to ALK inhibitors in non-small cell lung cancer: a narrative review [J].
Desai, Aakash ;
Lovly, Christine M. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) :615-628
[10]   Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer [J].
Gainor, Justin F. ;
Dardaei, Leila ;
Yoda, Satoshi ;
Friboulet, Luc ;
Leshchiner, Ignaty ;
Katayama, Ryohei ;
Dagogo-Jack, Ibiayi ;
Gadgeel, Shirish ;
Schultz, Katherine ;
Singh, Manrose ;
Chin, Emily ;
Parks, Melissa ;
Lee, Dana ;
DiCecca, Richard H. ;
Lockerman, Elizabeth ;
Huynh, Tiffany ;
Logan, Jennifer ;
Ritterhouse, Lauren L. ;
Le, Long P. ;
Muniappan, Ashok ;
Digumarthy, Subba ;
Channick, Colleen ;
Keyes, Colleen ;
Getz, Gad ;
Dias-Santagata, Dora ;
Heist, Rebecca S. ;
Lennerz, Jochen ;
Sequist, Lecia V. ;
Benes, Cyril H. ;
Iafrate, A. John ;
Mino-Kenudson, Mari ;
Engelman, Jeffrey A. ;
Shaw, Alice T. .
CANCER DISCOVERY, 2016, 6 (10) :1118-1133